These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21317201)

  • 1. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
    Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
    Rudolph A; Sainz J; Hein R; Hoffmeister M; Frank B; Försti A; Brenner H; Hemminki K; Chang-Claude J
    Endocr Relat Cancer; 2011 Jun; 18(3):371-84. PubMed ID: 21490239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect.
    Su MT; Chen CH; Kuo PH; Hsu CC; Lee IW; Pan HA; Chen YT; Kuo PL
    Fertil Steril; 2010 Jan; 93(1):141-9. PubMed ID: 18980759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
    Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
    BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
    Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
    Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
    Potocnik U; Glavac D; Dean M
    Cancer Genet Cytogenet; 2008 May; 183(1):28-34. PubMed ID: 18474294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's disease.
    Goumidi L; Dahlman-Wright K; Tapia-Paez I; Matsson H; Pasquier F; Amouyel P; Kere J; Lambert JC; Meirhaeghe A
    J Alzheimers Dis; 2011; 26(3):431-9. PubMed ID: 21673408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
    Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
    Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of genetic polymorphisms in HSD17B1, HSD17B2 and SHBG genes with hepatocellular carcinoma risk.
    Zhang LS; Yuan F; Guan X; Li J; Liu XL; Sun J; Liu B; Ma W; Deng FM
    Pathol Oncol Res; 2014 Jul; 20(3):661-6. PubMed ID: 24563232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk.
    Frank B; Hoeft B; Hoffmeister M; Linseisen J; Breitling LP; Chang-Claude J; Brenner H; Nieters A
    Carcinogenesis; 2011 Feb; 32(2):190-6. PubMed ID: 21047993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis.
    Lamp M; Peters M; Reinmaa E; Haller-Kikkatalo K; Kaart T; Kadastik U; Karro H; Metspalu A; Salumets A
    Gynecol Endocrinol; 2011 Jun; 27(6):425-33. PubMed ID: 20586553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer risk associated with hormone use varies by expression of estrogen receptor-β.
    Rudolph A; Toth C; Hoffmeister M; Roth W; Herpel E; Schirmacher P; Brenner H; Chang-Claude J
    Cancer Res; 2013 Jun; 73(11):3306-15. PubMed ID: 23585455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
    Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
    Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.
    Liao LH; Zhang H; Lai MP; Lau KW; Lai AK; Zhang JH; Wang Q; Wei W; Chai JH; Lung ML; Tai SS; Wu M
    Clin Chim Acta; 2007 May; 380(1-2):191-6. PubMed ID: 17368604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.